


| Active ingredients |
| Date of last message | Type of reason | AM designation | |
| Aprepitant | Change notification | 19.12.2025 | Other | EMEND 125 mg powder for oral suspension – OPXXXXmg | |
| Erythromycin | Initial report | 19.12.2025 | Production problem | Aknemycin solution | |
| Fibrinogen, human | Change notification | 19.12.2025 | Production problem | Haemocomplettan P 1g | |
| Fibrinogen, human | Change notification | 19.12.2025 | Production problem | Haemocomplettan P 2g | |
| Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y) | Change notification | 19.12.2025 | Other | Ferrlecit 62.5 mg | |
| Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y) | Change notification | 19.12.2025 | Other | Ferrlecit 40 mg | |
| Posaconazole | Change notification | 19.12.2025 | Production problem | Noxafil | |
| Esomeprazole hemimagnesium | Change notification | 19.12.2025 | Production problem | ESOMEPRAZOLE BASICS 40 mg gastro-resistant hard capsules | |
| Candesartan cilexetil | Change notification | 19.12.2025 | Other | CANDESARTAN BASICS 32 mg tablets | |
| Candesartan cilexetil | Change notification | 19.12.2025 | Other | CANDESARTAN BASICS 16 mg tablets | |
| Candesartan cilexetil | Change notification | 19.12.2025 | Other | CANDESARTAN BASICS 8 mg tablets | |
| Candesartan cilexetil | Change notification | 19.12.2025 | Other | CANDESARTAN BASICS 4 mg tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 19.12.2025 | Other | ATORVASTATIN BASICS 80 mg film-coated tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 19.12.2025 | Other | ATORVASTATIN BASICS 30 mg film-coated tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 19.12.2025 | Other | ATORVASTATIN BASICS 20 mg film-coated tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 19.12.2025 | Other | ATORVASTATIN BASICS 10 mg film-coated tablets | |
| Ciprofloxacin hydrochloride monohydrate | Change notification | 19.12.2025 | Other | CIPRO BASICS 750 mg film-coated tablets | |
| Ciprofloxacin hydrochloride monohydrate | Change notification | 19.12.2025 | Other | CIPRO BASICS 250 mg film-coated tablets | |
| Ezetimibe; simvastatin | Change notification | 19.12.2025 | Production problem | EZETIMIB/SIMVA BASICS 10 mg/80 mg tablets | |
| Ezetimibe; simvastatin | Change notification | 19.12.2025 | Production problem | EZETIMIB/SIMVA BASICS 10 mg/40 mg tablets | |
| Ezetimibe; simvastatin | Change notification | 19.12.2025 | Production problem | EZETIMIB/SIMVA BASICS 10 mg/20 mg tablets | |
| Ezetimibe; simvastatin | Change notification | 19.12.2025 | Production problem | EZETIMIBE/SIMVA BASICS 10 mg/10 mg tablets | |
| Esomeprazole hemimagnesium | Change notification | 19.12.2025 | Production problem | ESOMEPRAZOLE BASICS 20 mg gastro-resistant hard capsules | |
| Betamethasone acetate (Ph.Eur.); Betamethasone dihydrogen phosphate disodium (Ph.Eur.) | Initial report | 19.12.2025 | Other | Celestan Depot | |
| Mesalazine | Change notification | 19.12.2025 | Other | Claversal 500 mg tablets | |
| Terazosin hydrochloride dihydrate | Change notification | 19.12.2025 | Other | Heitrin 2 mg | |
| Proxymetacaine hydrochloride | Change notification | 19.12.2025 | Production problem | Proparacaine-POS 0.5% | |
| Gentamicin sulfate | Change notification | 19.12.2025 | Production problem | Gentamicin POS | |
| Phenylephrine hydrochloride | Change notification | 19.12.2025 | Production problem | Neosynephrine-POS 10% | |
| Epoetin theta | Initial report | 18.12.2025 | Production problem | Eporatio 4000 IU/0.5 ml injection solution in pre-filled syringe – OP (6×0.5 ml) | |
| Etanercept | Initial report | 18.12.2025 | Other | Nepexto 50 mg solution for injection in a pre-filled syringe | |
| Etanercept | Initial report | 18.12.2025 | Other | Nepexto 50 mg solution for injection in a pre-filled syringe | |
| Etanercept | Initial report | 18.12.2025 | Other | Nepexto 50 mg solution for injection in a pre-filled pen | |
| Etanercept | Initial report | 18.12.2025 | Other | Nepexto 50 mg solution for injection in a pre-filled pen | |
| Rifampicin sodium | Change notification | 18.12.2025 | Other | Eremfat i.v. 600mg | |
| Urapidil | Change notification | 18.12.2025 | Production problem | Urapidil Bluefish 90 mg hard capsules, delayed release | |
| Urapidil | Change notification | 18.12.2025 | Production problem | Urapidil Bluefish 30 mg hard capsules, delayed release | |
| Hydromorphone hydrochloride | Change notification | 18.12.2025 | Other | Hydromorphone PAINBREAK 8 mg prolonged-release tablets | |
| Hydromorphone hydrochloride | Change notification | 18.12.2025 | Other | Hydromorphone PAINBREAK 4 mg prolonged-release tablets | |
| Hydromorphone hydrochloride | Change notification | 18.12.2025 | Other | Hydromorphone PAINBREAK 24 mg prolonged-release tablets | |
| Hydromorphone hydrochloride | Change notification | 18.12.2025 | Other | Hydromorphone PAINBREAK 16 mg prolonged-release tablets | |
| Dexamethasone dihydrogen phosphate disodium (Ph.Eur.) | Initial report | 18.12.2025 | Other | Dexafluid 1 mg/ml eye drops | |
| Ipratropium bromide (Ph.Eur.) | Change notification | 18.12.2025 | Production problem | Ipratropium Teva 250 micrograms/1 ml solution for nebulizer | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 18.12.2025 | Other | Quetiapine AbZ 150 mg prolonged-release tablets | |
| Nitrendipine | Change notification | 18.12.2025 | Other | Nitrendipine AbZ 10 mg tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 18.12.2025 | Other | Quetiapine-ratiopharm 300 mg prolonged-release tablets | |
| Pramipexole dihydrochloride monohydrate | Change notification | 18.12.2025 | Other | Pramipexole-ratiopharm 0.52 mg prolonged-release tablets | |
| Propranolol hydrochloride | Change notification | 18.12.2025 | Other | Propra-ratiopharm 10 mg film-coated tablets | |
| Propranolol hydrochloride | Change notification | 18.12.2025 | Other | Propra-ratiopharm 40 mg film-coated tablets | |
| Propranolol hydrochloride | Change notification | 18.12.2025 | Other | Propra-ratiopharm 80 mg film-coated tablets | |
| Nitrendipine | Change notification | 18.12.2025 | Other | Nitrendipine-ratiopharm 20 mg tablets | |
| Galantamine hydrobromide | Change notification | 18.12.2025 | Other | Galantamine-ratiopharm 24 mg hard capsules, delayed release | |
| Galantamine hydrobromide | Change notification | 18.12.2025 | Other | Galantamine-ratiopharm 16 mg hard capsules, delayed release | |
| Galantamine hydrobromide | Change notification | 18.12.2025 | Other | Galantamine-ratiopharm 8 mg hard capsules, delayed release | |
| Doxepine hydrochloride (Ph.Eur.) | Change notification | 18.12.2025 | Other | Doxepin-ratiopharm 50 mg film-coated tablets | |
| Doxepine hydrochloride (Ph.Eur.) | Change notification | 18.12.2025 | Other | Doxepin-ratiopharm 25 mg film-coated tablets | |
| Dexamethasone dihydrogen phosphate disodium (Ph.Eur.) | Change notification | 18.12.2025 | Other | Dexa-ratiopharm 4 mg solution for injection | |
| Clonidine hydrochloride | Change notification | 18.12.2025 | Other | Clonidine-ratiopharm 300 | |
| Clonidine hydrochloride | Change notification | 18.12.2025 | Other | Clonidine-ratiopharm 150 | |
| Clonidine hydrochloride | Change notification | 18.12.2025 | Other | Clonidine-ratiopharm 75 | |
| Cinacalcet hydrochloride | Change notification | 18.12.2025 | Other | Cinacalcet-ratiopharm 30 mg film-coated tablets | |
| Alprazolam | Change notification | 18.12.2025 | Other | Alprazolam-ratiopharm 1.0 mg tablets | |
| Alprazolam | Change notification | 18.12.2025 | Other | Alprazolam-ratiopharm 0.5 mg tablets | |
| Nitrendipine | Change notification | 18.12.2025 | Other | Nitrendipine AL 10 | |
| Anastrozole | Change notification | 18.12.2025 | Other | Anastrozole Denk 1 mg film-coated tablets | |
| Folic acid hydrate (with information on water content (1:x)) | Change notification | 18.12.2025 | Other | Folic acid AL 5 mg tablets | |
| Erythromycin lactobionate | Change notification | 17.12.2025 | Production problem | Erythrocin-i.v. 1.0 g | |
| Methyldopa (Ph.Eur.) | Change notification | 17.12.2025 | Production problem | Methyldopa STADA 250 mg film-coated tablet | |
| Insulin aspart | Change notification | 17.12.2025 | Other | NovoRapid PumpCart 100 E/ml solution for injection in cartridge – OP[5x(5×1.6ml)] | |
| Paliperidone palmitate | Change notification | 17.12.2025 | Other | Paliperidone AL 50 mg Depot injection suspension in a pre-filled syringe | |
| Aprepitant | Change notification | 17.12.2025 | Other | Aprepitant AL 80 mg hard capsules | |
| Aprepitant | Change notification | 17.12.2025 | Other | Aprepitant AL 125 mg hard capsules | |
| Aprepitant | Change notification | 17.12.2025 | Other | Aprepitant AL 125 mg and 80 mg hard capsules | |
| Zoledronic acid monohydrate | Change notification | 17.12.2025 | Other | Zoledronic acid AL 4 mg/100 ml solution for infusion | |
| Potassium canrenoate | Initial report | 17.12.2025 | Production problem | Aldactone 10 ml Canrenoate | |
| Salbutamol sulfate | Initial report | 16.12.2025 | Other | Bronchospray novo | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 16.12.2025 | Other | Atorvastatin Micro Labs 10 mg film-coated tablets | |
| Levetiracetam | Change notification | 16.12.2025 | Production problem | Levetiracetam Holsten 250 mg film-coated tablets | |
| Moxifloxacin hydrochloride (Ph.Eur.) ((with information on water content (1:x))) | Change notification | 16.12.2025 | Other | Moxifloxacin Holsten 400 mg film-coated tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 16.12.2025 | Other | Quetiapine AL 50 mg prolonged-release tablets | |
| Propofol | Initial report | 16.12.2025 | Production problem | Propofol-Lipuro 10 mg/ml | |
| Isosorbide mononitrate | Change notification | 16.12.2025 | Other | ISMN AL40 retard | |
| Isosorbide mononitrate | Change notification | 16.12.2025 | Other | ISMN AL 100 retard | |
| Primidone | Initial report | 16.12.2025 | Other | Primidone Holsten | |
| Amikacin sulfate | Change notification | 16.12.2025 | Production problem | Amikacin B. Braun 5 mg/ml infusion solution | |
| Amoxicillin trihydrate | Change notification | 16.12.2025 | Other | Amoxicillin AL TS | |
| Cefixime 3 H<2>O | Change notification | 16.12.2025 | Other | Cefixime AL 100 mg/5 ml powder for oral suspension | |
| Dexketoprofen trometamol | Change notification | 16.12.2025 | Production problem | Sympal inject 50 mg solution for injection/infusion | |
| Selegiline hydrochloride | Change notification | 16.12.2025 | Other | Selegiline AL 5 | |
| Clonidine hydrochloride | Change notification | 15.12.2025 | Production problem | Clonistada 0.15 mg tablets | |
| Lidocaine hydrochloride monohydrate | Change notification | 15.12.2025 | Other | Xylocaine Gel 2% | |
| Lidocaine | Change notification | 15.12.2025 | Other | XYLOCAIN PUMP SPRAY dental | |
| Calcium chloride dihydrate; histidine; histidine hydrochloride monohydrate; potassium hydrogen 2-oxopentanedioate; potassium chloride; magnesium chloride hexahydrate; mannitol (Ph.Eur.); sodium chloride; tryptophan | Change notification | 15.12.2025 | Production problem | Custodiol | |
| Rosuvastatin calcium (Ph.Eur.) | Change notification | 15.12.2025 | Other | Rosuvastatin Aurobindo 20 mg film-coated tablets | |
| Buprenorphine hydrochloride | Change notification | 15.12.2025 | Other | Buprenorphine PUREN 8 mg sublingual tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 15.12.2025 | Other | Atorvastatin PUREN 40 mg film-coated tablets | |
| Alprazolam | Change notification | 15.12.2025 | Other | Alprazolam – 1 A Pharma 0.5 mg tablets | |
| Oxytocin | Change notification | 15.12.2025 | Production problem | Oxytocin 3 I.E. Hexal | |
| Galantamine hydrobromide | Change notification | 15.12.2025 | Other | Galantamine – 1A Pharma 24 mg prolonged-release hard capsules | |
| Galantamine hydrobromide | Change notification | 15.12.2025 | Other | Galantamine – 1A Pharma 8 mg prolonged-release hard capsules | |
| Galantamine hydrobromide | Change notification | 15.12.2025 | Other | Galantamine – 1A Pharma 16 mg prolonged-release hard capsules | |
| Oxcarbazepine | Change notification | 15.12.2025 | Other | Oxcarbazepine – 1 A Pharma 60 mg/ml oral suspension | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 15.12.2025 | Production problem | Quetiapine HEXAL 300 mg prolonged-release tablets | |
| Indapamide; Perindopril arginine | Initial report | 15.12.2025 | Other | Perindopril arginine/indapamide Viatris 5 mg/1.25 mg film-coated tablets |
| Active ingredients | Status | Update | Specialty |
| methylphenidate | Supply tension | 19/12/2025 | Quasym LP, modified-release capsule |
| fluorouracil | Supply tension | 19/12/2025 | Fluorouracil Pfizer 50 mg/mL, solution for dilution for infusion – 20 mL and 100 mL vials |
| medroxyprogesterone | Supply tension | 18/12/2025 | Depo Prodasone 500 mg, injectable suspension |
| ifosfamide | Supply tension | 18/12/2025 | Holoxan 1000 mg powder for solution for injection and 2000 mg powder for parenteral use |
| synthetic vitamin A concentrate, oil form | Marketing discontinuation | 17/12/2025 | Vitamin A Dulcis 25,000 IU per 100 g, ophthalmic ointment – (imported from Vitamin A Blache) |
| ondansetron | Supply tension | 17/12/2025 | Zophren 2 mg/mL, injectable solution in ampoule (IV) |
| trandolapril | Supply tension | 17/12/2025 | Trandolapril 2 mg and 4 mg |
| trandolapril | Return to availability | 17/12/2025 | Trandolapril 0.5 mg, capsules |
| venlafaxine | Supply tension | 17/12/2025 | Specialties based on Venlafaxine LP 37.5 mg and LP 75 mg in extended-release capsules |
| diltiazem (hydrochloride) | Supply tension | 17/12/2025 | Tildiem 25 mg, powder and solution for intravenous injection |
| amphotericin B | Return to availability | 15/12/2025 | Fungizone 10%, oral suspension |
| venlafaxine | Return to availability | 15/12/2025 | Venlafaxine Viatris 50 mg, film-coated tablet |
| digoxin | Return to availability | 15/12/2025 | Digoxin Nativelle 5 µg/0.1 ml, oral solution in drops |
| rifampicin | Oral Liquid | 20 mg/mL | Anticipated | Available | Unexpected increase in consumer demand | 19/12/2025 |
| salbutamol sulfate | Inhalation, conventional | 3 mg | Current | Unavailable | Manufacturing | 19/12/2025 |
| salbutamol sulfate | Inhalation, conventional | 6 mg | Current | Unavailable | Manufacturing | 19/12/2025 |
| topiramate | Tablet, film coated | 50 mg | Resolved | Available | Manufacturing | 19/12/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 832.5 mg | Current | Limited Availability | Manufacturing | 19/12/2025 |
| lamotrigine | Tablet, chewable | 200 mg | Resolved | Available | Manufacturing | 19/12/2025 |
| olanzapine | Tablet, orally disintegrating | 5 mg | Resolved | Available | Manufacturing | 19/12/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Current | Unavailable | Manufacturing | 19/12/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Current | Limited Availability | Manufacturing | 19/12/2025 |
| exemestane | Tablet, sugar coated | 25 mg | Current | Limited Availability | Manufacturing | 19/12/2025 |
| quetiapine fumarate | Tablet, modified release | 345.39 mg | Current | Unavailable | Manufacturing | 19/12/2025 |
| quetiapine fumarate | Tablet, modified release | 230.26 mg | Current | Limited Availability | Manufacturing | 19/12/2025 |
| clindamycin hydrochloride | Capsule, hard | 162.87 mg | Resolved | Available | Manufacturing | 19/12/2025 |
| levetiracetam | Injection, intravenous infusion | 100 mg/mL | Anticipated | Available | Manufacturing | 19/12/2025 |
| phenylephrine hydrochloride~prednisolone acetate | Eye Drops, suspension | 1.2 mg/mL~10 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 19/12/2025 |
| isotretinoin | Capsule, soft | 20 mg | Anticipated | Available | Manufacturing | 19/12/2025 |
| irbesartan | Tablet, film coated | 75 mg | Current | Unavailable | Manufacturing | 19/12/2025 |
| olmesartan medoxomil~hydrochlorothiazide | Tablet | 20 mg~12.5 mg | Current | Unavailable | Manufacturing | 19/12/2025 |
| acamprosate calcium | Tablet, enteric coated | 333 mg | Resolved | Available | Manufacturing | 19/12/2025 |
| lacosamide | Tablet, film coated | 50 mg | Anticipated | Available | Manufacturing | 19/12/2025 |
| risperidone | Tablet, film coated | 2 mg | Current | Limited Availability | Manufacturing | 19/12/2025 |
| lorazepam | Tablet | 1 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 19/12/2025 |
| lamotrigine | Tablet, chewable | 200 mg | Current | Limited Availability | Manufacturing | 19/12/2025 |
| levothyroxine sodium | Tablet, uncoated | 200 microgram | Current | Unavailable | Manufacturing | 19/12/2025 |
| risperidone | Oral Liquid, solution | 1 mg/mL | Current | Unavailable | Manufacturing | 19/12/2025 |
| ondansetron hydrochloride dihydrate | Tablet, film coated | 4.986 mg | Current | Limited Availability | Manufacturing | 19/12/2025 |
| anastrozole | Tablet, film coated | 1 mg | Anticipated | Available | Manufacturing | 19/12/2025 |
| hydralazine hydrochloride | Injection, powder for | 20 mg | Current | Unavailable | Manufacturing | 19/12/2025 |
| isotretinoin | Capsule, soft | 20 mg | Current | Unavailable | Manufacturing | 19/12/2025 |
| isotretinoin | Capsule, soft | 10 mg | Current | Unavailable | Manufacturing | 19/12/2025 |
| teicoplanin~water for injections | Diluent, not applicable~Injection, powder for | 400 mg~3.14 mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 19/12/2025 |
| alfuzosin hydrochloride | Tablet, modified release | 10 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 19/12/2025 |
| sodium pyrophosphate | Injection, powder for | 30 mg | Current | Unavailable | Manufacturing | 18/12/2025 |
| doxorubicin hydrochloride | Injection | 2 mg/mL | Anticipated | Available | Manufacturing | 18/12/2025 |
| atomoxetine hydrochloride | Capsule, hard | 11.43 mg | Current | Unavailable | Manufacturing | 18/12/2025 |
| cyproterone acetate | Tablet, uncoated | 100 mg | Anticipated | Available | Manufacturing | 18/12/2025 |
| ambrisentan | Tablet, film coated | 5 mg | Anticipated | Available | Manufacturing | 18/12/2025 |
| dantrolene sodium hemiheptahydrate | Injection, powder for | 20 mg | Anticipated | Available | Manufacturing | 17/12/2025 |
| glipizide | Tablet, uncoated | 5 mg | Resolved | Available | Manufacturing | 17/12/2025 |
| cyproterone acetate | Tablet, uncoated | 50 mg | Current | Limited Availability | Manufacturing | 17/12/2025 |
| plerixafor | Injection, solution | 20 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 17/12/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Current | Unavailable | Manufacturing | 17/12/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 43.38 mg | Current | Unavailable | Manufacturing | 17/12/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 17/12/2025 |
| armodafinil | Tablet, uncoated | 250 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 17/12/2025 |
| armodafinil | Tablet, uncoated | 150 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 17/12/2025 |
| cisatracurium besilate | Injection, solution | 7.04 mg | Current | Limited Availability | Manufacturing | 17/12/2025 |
| metformin hydrochloride | Tablet, modified release | 500 mg | Current | Unavailable | Manufacturing | 17/12/2025 |
| risperidone | Oral Liquid, solution | 1 mg/mL | Current | Unavailable | Manufacturing | 17/12/2025 |
| levothyroxine sodium | Tablet | .075 mg | Anticipated | Available | Manufacturing | 17/12/2025 |
| ramipril | Tablet, uncoated | 1.25 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 17/12/2025 |
| Teriparatide | Injection, solution | 250 microgram/mL | Current | Unavailable | Manufacturing | 17/12/2025 |
| metronidazole | Tablet, film coated | 400 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 17/12/2025 |
| stannous chloride dihydrate | Injection, powder for | 19.2 microgram/mL | Current | Emergency Supply Only | Manufacturing | 17/12/2025 |
| carbidopa monohydrate~levodopa | Tablet, uncoated | 26.9 mg~100 mg | Anticipated | Available | Manufacturing | 17/12/2025 |
| labetalol hydrochloride | Tablet, film coated | 200 mg | Anticipated | Available | Manufacturing | 17/12/2025 |
| olanzapine | Tablet, film coated | 5 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 17/12/2025 |
| midazolam | Injection, solution | 1 mg/mL | Resolved | Available | Manufacturing | 17/12/2025 |
| hydrochlorothiazide~enalapril maleate | Tablet, uncoated | 6 mg~20 mg | Resolved | Available | Manufacturing | 17/12/2025 |
| olanzapine | Wafer | 5 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 17/12/2025 |
| cefalexin monohydrate | Capsule, hard | 263 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 17/12/2025 |
| metformin hydrochloride | Tablet, film coated | 500 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 17/12/2025 |
| etoposide phosphate | Injection, powder for | 1136 mg | Anticipated | Available | Manufacturing | 17/12/2025 |
| gabapentin | Capsule, hard | 400 mg | Current | Limited Availability | Manufacturing | 16/12/2025 |
| cyproterone acetate | Tablet, uncoated | 50 mg | Current | Unavailable | Unexpected increase in consumer demand | 16/12/2025 |
| calcitonin salmon | Injection, solution | 100 IU/mL | Anticipated | Available | Unexpected increase in consumer demand | 16/12/2025 |
| valaciclovir | Tablet, film coated | 500 mg | Resolved | Available | Manufacturing | 16/12/2025 |
| benzathine benzylpenicillin tetrahydrate | Injection, suspension | 1200000 USP Unit | Current | Limited Availability | Manufacturing | 16/12/2025 |
| galantamine hydrobromide | Capsule, modified release | 20.512 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 16/12/2025 |
| galantamine hydrobromide | Capsule, modified release | 30.768 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 16/12/2025 |
| leflunomide | Tablet, film coated | 20 mg | Resolved | Available | Manufacturing | 16/12/2025 |
| Somatropin | Injection, powder for | 12 mg/mL | Resolved | Available | Unexpected increase in consumer demand | 16/12/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 86.76 mg | Current | Limited Availability | Manufacturing | 16/12/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 21.69 mg | Current | Unavailable | Manufacturing | 16/12/2025 |
| valsartan~hydrochlorothiazide | Tablet, film coated | 160 mg~12.5 mg | Anticipated | Available | Manufacturing | 16/12/2025 |
| oseltamivir phosphate | Oral Liquid, powder for | 7.88 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 16/12/2025 |
| levodopa~carbidopa monohydrate~entacapone | Tablet, film coated | 200 mg~54 mg~200 mg | Resolved | Available | Manufacturing | 16/12/2025 |
| levodopa~carbidopa monohydrate~entacapone | Tablet, film coated | 75 mg~20.25 mg~200 mg | Resolved | Available | Manufacturing | 16/12/2025 |
| carbidopa monohydrate~entacapone~levodopa | Tablet, film coated | 13.5 mg~200 mg~50 mg | Resolved | Available | Manufacturing | 16/12/2025 |
| levodopa~entacapone~carbidopa monohydrate | Tablet, film coated | 100 mg~200 mg~27 mg | Resolved | Available | Manufacturing | 16/12/2025 |
| entacapone~levodopa~carbidopa monohydrate | Tablet, film coated | 200 mg~125 mg~33.75 mg | Resolved | Available | Manufacturing | 16/12/2025 |
| entacapone~carbidopa monohydrate~levodopa | Tablet, film coated | 200 mg~40.5 mg~150 mg | Resolved | Available | Manufacturing | 16/12/2025 |
| risperidone | Tablet, film coated | 3 mg | Current | Limited Availability | Manufacturing | 16/12/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 60 mg | Current | Limited Availability | Manufacturing | 16/12/2025 |
| quetiapine fumarate | Tablet, modified release | 57.5 mg | Current | Limited Availability | Unexpected increase in consumer demand | 16/12/2025 |
| stiripentol | Capsule | 500 mg | Anticipated | Available | Manufacturing | 16/12/2025 |
| lacosamide | Tablet, film coated | 100 mg | Resolved | Available | Manufacturing | 16/12/2025 |
| metaraminol tartrate | Injection, solution | 19 mg | Current | Unavailable | Manufacturing | 16/12/2025 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Resolved | Available | Manufacturing | 16/12/2025 |
| nitrofurantoin | Capsule, hard | 100 mg | Current | Unavailable | Unexpected increase in consumer demand | 16/12/2025 |
| sacubitril~valsartan | Tablet, film coated | 97.2 mg~102.8 mg | Current | Unavailable | Manufacturing | 16/12/2025 |
| rivaroxaban | Tablet, film coated | 15 mg | Resolved | Available | Manufacturing | 16/12/2025 |
| nitrofurantoin | Capsule, hard | 100 mg | Current | Limited Availability | Unexpected increase in consumer demand | 16/12/2025 |
| aripiprazole monohydrate | Injection, powder for | 416.07 mg | Current | Unavailable | Manufacturing | 16/12/2025 |
| lidocaine hydrochloride | Injection, solution | 10 mg/mL | Resolved | Available | Manufacturing | 16/12/2025 |
| pramipexole dihydrochloride monohydrate | Tablet, uncoated | 1 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 16/12/2025 |
| pramipexole dihydrochloride monohydrate | Tablet, uncoated | .125 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 16/12/2025 |
| diltiazem hydrochloride | Capsule, modified release | 180 mg | Current | Limited Availability | Manufacturing | 16/12/2025 |
| diltiazem hydrochloride | Capsule, modified release | 360 mg | Current | Unavailable | Manufacturing | 16/12/2025 |
| diltiazem hydrochloride | Capsule, modified release | 360 mg | Anticipated | Available | Manufacturing | 16/12/2025 |
| flunitrazepam | Tablet, film coated | 1 mg | Current | Limited Availability | Manufacturing | 16/12/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 20 mg | Current | Limited Availability | Manufacturing | 16/12/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 30 mg | Resolved | Available | Manufacturing | 16/12/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 40 mg | Current | Unavailable | Manufacturing | 16/12/2025 |
| simvastatin | Tablet, film coated | 5 mg | Current | Limited Availability | Manufacturing | 16/12/2025 |
| Pancreatic extract | Capsule, enteric | 300 mg | Current | Limited Availability | Unexpected increase in consumer demand | 15/12/2025 |
| lansoprazole | Capsule, enteric | 30 mg | Resolved | Available | Manufacturing | 15/12/2025 |
| avanafil | Tablet, uncoated | 200 mg | Anticipated | Available | Unexpected increase in consumer demand | 15/12/2025 |
| benzathine benzylpenicillin tetrahydrate | Injection, suspension | 600000 USP Unit | Current | Unavailable | Manufacturing | 15/12/2025 |
| lacosamide | Tablet, film coated | 50 mg | Resolved | Available | Manufacturing | 15/12/2025 |
| lacosamide | Tablet, film coated | 150 mg | Resolved | Available | Manufacturing | 15/12/2025 |
| Pancreatic extract | Capsule | 420 mg | Current | Limited Availability | Unexpected increase in consumer demand | 15/12/2025 |
| estradiol | Drug delivery system, transdermal | 1.17 mg | Current | Unavailable | Manufacturing | 15/12/2025 |
| lanreotide acetate | Injection, solution | 133.33 mg | Current | Unavailable | Manufacturing | 15/12/2025 |
| lanreotide acetate | Injection, solution | 100 mg | Current | Unavailable | Manufacturing | 15/12/2025 |
| imipramine hydrochloride | Tablet, sugar coated | 25 mg | Current | Unavailable | Manufacturing | 15/12/2025 |
| Generic Name | Shortage Status | Revision Date | Created Date |
| Insulin Aspart Injection | Current Shortages | 19-Dec-25 | 10-Nov-23 |
| Lenalidomide Capsules | Current Shortages | 19-Dec-25 | 11-Jan-24 |
| Lidocaine Injection | Current Shortages | 19-Dec-25 | 23-Jun-15 |
| Posaconazole Injection | Resolved Shortages | 19-Dec-25 | 18-Dec-25 |
| Dorzolamide Ophthalmic Solution | Current Shortages | 18-Dec-25 | 19-Jun-24 |
| Fentanyl Citrate Injection | Current Shortages | 18-Dec-25 | 8-May-17 |
| Methylprednisolone Acetate Injection | Current Shortages | 18-Dec-25 | 25-Aug-25 |
| Methylprednisolone Sodium Succinate Injection | Current Shortages | 18-Dec-25 | 23-Mar-23 |
| Metyrosine Capsules | Current Shortages | 18-Dec-25 | 3-Sep-25 |
| Mometasone Furoate Aerosol for Oral Inhalation | Current Shortages | 18-Dec-25 | 29-Jul-25 |
| Mometasone Furoate and Formoterol Fumarate Inhalation Aerosol | Current Shortages | 18-Dec-25 | 29-Aug-25 |
| Nalbuphine Injection | Current Shortages | 18-Dec-25 | 8-Nov-22 |
| Nitroglycerin Injection | Current Shortages | 18-Dec-25 | 24-Aug-23 |
| Penicillin V Potassium Oral Presentations | Current Shortages | 18-Dec-25 | 17-May-23 |
| Somatropin Injection | Resolved Shortages | 18-Dec-25 | 22-Nov-22 |
| Terbutaline Sulfate Injection | Current Shortages | 18-Dec-25 | 21-Jan-25 |
| 5% Dextrose Injection Small Volume Bags | Current Shortages | 16-Dec-25 | 4-Feb-22 |
| Acyclovir Injection | Current Shortages | 16-Dec-25 | 16-Dec-25 |
| Dobutamine Injection | Current Shortages | 16-Dec-25 | 1-Mar-17 |
| Dopamine Hydrochloride Injection | Current Shortages | 16-Dec-25 | 9-Mar-22 |
| Fluorescein Sodium and Proparacaine Hydrochloride Ophthalmic Solution | Current Shortages | 16-Dec-25 | 26-Jul-19 |
| Flurazepam Capsules | Resolved Shortages | 16-Dec-25 | 10-Nov-23 |
| Gentamicin Injection | Current Shortages | 16-Dec-25 | 22-Feb-21 |
| Haloperidol Lactate Injection | Current Shortages | 16-Dec-25 | 9-Dec-20 |
| Lanthanum Carbonate Oral Presentations | Current Shortages | 16-Dec-25 | 2-Apr-25 |
| Naltrexone Tablets | Current Shortages | 16-Dec-25 | 7-Feb-24 |
| Valproate Sodium Injection | Current Shortages | 16-Dec-25 | 13-Aug-25 |
| Vancomycin Hydrochloride Injection | Current Shortages | 16-Dec-25 | 1-Jun-15 |
| Bacitracin Ophthalmic Ointment | Current Shortages | 15-Dec-25 | 12-Sep-24 |
| Eptifibatide Injection | Current Shortages | 15-Dec-25 | 20-May-20 |
| Moxifloxacin Tablets | Current Shortages | 15-Dec-25 | 6-Dec-23 |
| Varenicline tablets (Chantix) | Resolved Shortages | 15-Dec-25 | 24-Jun-21 |
December 19, 2025
December 19, 2025
December 18, 2025
December 17, 2025
December 16, 2025
December 15, 2025
Medicine supply notification: Nifedipine (Fortipine® LA) 40mg modified-release tablets
2025年12月8日、保健・社会福祉省(Department of Health and Social Care:DHSC)は、Nifedipine (Fortipine® LA) 40mg徐放性錠の医薬品供給通知(medicine supply notification)を発出した。

